Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

OLEMA PHARMACEUTICALS INC (OLMA)

208 + Investors. Track Smart Money conviction in OLMA. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +74
Streak
2Q ▲
Buyers last Q
74%

Smart Money Signals — OLMA

Based on 198 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added OLMA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
198 hedge funds hold OLMA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +32% more funds vs a year ago

fund count last 6Q
+48 new funds entered over the past year (+32% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 74% buying

145 buying52 selling
Last quarter: 145 funds were net buyers (86 opened a brand new position + 59 added to an existing one). Only 52 were sellers (40 trimmed + 12 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+65 vs last Q)

new funds entering per quarter
Funds opening a new OLMA position: 26 → 17 → 21 → 86. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 37% long-term, 34% new

■ 37% conviction (2yr+) ■ 28% medium ■ 34% new
Of the 198 current holders: 74 (37%) held >2 years, 56 held 1–2 years, and 68 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💰

Value +239% but shares only +35% — price-driven

Value
+239%
Shares
+34%
Last quarter: the total dollar value of institutional holdings rose +239%, but actual share count only changed +35%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

34 → 26 → 17 → 21 → 86 new funds/Q
New funds entering each quarter: 26 → 17 → 21 → 86. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Deep conviction — 49% of holders stayed 2+ years

■ 49% veterans ■ 15% 1-2yr ■ 37% new
Of 208 current holders: 101 (49%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 30% AUM from major funds

30% from top-100 AUM funds
32 of 198 holders rank in the top 100 by AUM, accounting for 30% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.3
out of 10
Moderate Exit Risk
Exit risk score 4.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — OLMA

In 2025 Q4, 145 hedge funds were net buyers of OLMA (86 opened a new position, 59 added to an existing one), while 52 reduced or exited (40 trimmed, 12 sold completely) — a 74% buyer ratio, indicating clear institutional accumulation. Net buying has persisted for two consecutive quarters, a positive momentum signal. 30% of total institutional value in OLMA is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +74 funds (more new holders than closures). Total institutional holders: 198.

Hedge Fund Ownership: OLMA

How many hedge funds hold OLMA — quarterly history vs. share price
Quarterly hedge fund ownership of OLMA vs. share price

Market Analysis: OLMA

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: OLMA

Healthcare Biotechnology

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

34 top-rated funds 4 high-conviction
Consensus
6.7
/ 10
breadth
×
Elite
3.4
/ 10
conviction
Hedge Fund Positioning: OLMA
2026 Q1 Stats Unlock in 5 days 208 + Investors

Track Smart Money conviction in OLMA. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 208 127 63.78%
13F Shares 92M 69M 34.5%
Total Value $2.28B $671M 239.49%
New Positions 90 22 +68
Increased Positions 64 40 +24
Closed Positions 13 16 -3
Reduced Positions 42 39 +3
Total Calls 8 4 100.0%
Total Puts 5 1 400.0%
PUT/CALL Ratio 0.62 0.25 Bullish

Statistics: OLMA

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

208 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in OLMA. Verified SEC 13F-HR filings.

Top 25 institutional holders of OLMA — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Defilade Capital Management, L.P. 3.15% 1,504,536 $22.4M
2 Siren, L.L.C. 1.97% 4,756,949 $70.9M
3 Pier Capital, LLC 0.33% 136,108 $2.0M
4 ACT CAPITAL MANAGEMENT, LLC 0.29% 25,000 $373K
5 Hennion & Walsh Asset Management, Inc. 0.24% 481,485 $7.2M
6 PORTLAND INVESTMENT COUNSEL INC. 0.24% 50,000 $746K
7 Optimize Financial Inc 0.15% 20,567 $307K
8 PSP Research LLC 0.11% 10,000 $149K
9 Headlands Technologies LLC 0.10% 59,374 $885K
10 Jump Financial, LLC 0.09% 452,966 $6.8M
11 TEMA ETFS LLC 0.08% 79,243 $1.2M
12 CONWAY CAPITAL MANAGEMENT, INC. 0.07% 10,000 $149K
13 FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. 0.06% 116,812 $1.7M
14 Candriam S.C.A. 0.06% 759,513 $11.3M
15 Virtus Investment Advisers, LLC 0.03% 8,250 $123K
16 PROFUND ADVISORS LLC 0.03% 58,577 $873K
17 AXQ CAPITAL, LP 0.03% 14,633 $218K
18 Y-Intercept (Hong Kong) Ltd 0.03% 90,375 $1.3M
19 Inscription Capital, LLC 0.02% 15,273 $228K
20 Virtu Financial LLC 0.02% 36,161 —
21 SEB Asset Management AB 0.02% 339,461 $5.1M
22 JENNISON ASSOCIATES LLC 0.02% 1,822,123 $27.2M
23 Caitong International Asset Management Co., Ltd 0.02% 5,970 $89K
24 China Universal Asset Management Co., Ltd. 0.02% 14,225 $212K
25 Entropy Technologies, LP 0.01% 15,773 $235K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — OLEMA PHARMACEUTICALS INC (OLMA)

What does the Smart Money Trend signal show for OLMA?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added OLMA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for OLMA?

More buyers than sellers — 74% buying: Last quarter: 145 funds were net buyers (86 opened a brand new position + 59 added to an existing one). Only 52 were sellers (40 trimmed + 12 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for OLMA holders?

Strong quality — 30% AUM from major funds: 32 of 198 holders rank in the top 100 by AUM, accounting for 30% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held OLMA?

Mixed — 37% long-term, 34% new: Of the 198 current holders: 74 (37%) held >2 years, 56 held 1–2 years, and 68 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.